United Therapeutics buy Royal Bank of Canada
Start price
06.08.26
/
50%
€461.70
Target price
06.08.27
€586.01
Performance (%)
0.93%
Price
07.08.26
€466.00
Summary
This prediction is currently active. The BUY prediction by Royal_Bank_of_Canada for United Therapeutics is nearly unchanged. This prediction currently runs until 06.08.27. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| United Therapeutics | 0.93% |
| iShares Core DAX® | 2,57 % |
| iShares Nasdaq 100 | 4,86 % |
| iShares Nikkei 225® | 5,59 % |
| iShares S&P 500 | 3,25 % |
Comments by Royal_Bank_of_Canada for this prediction
In the thread United Therapeutics diskutieren
United Therapeutics (UTHR) had its price target lowered by Royal Bank Of Canada from $704.00 to $677.00. They now have an "outperform" rating on the stock.
Ratings data for UTHR provided by MarketBeat
Stopped prediction by Royal_Bank_of_Canada for United Therapeutics
United Therapeutics
Start price
Target price
Perf. (%)
€493.50
07.07.26
07.07.26
€615.51
07.07.27
07.07.27
-5.57%
07.08.26
07.08.26
United Therapeutics
Start price
Target price
Perf. (%)
€485.40
07.05.26
07.05.26
€596.27
07.05.27
07.05.27
-4.00%
07.08.26
07.08.26
United Therapeutics
Start price
Target price
Perf. (%)
€426.90
26.02.26
26.02.26
€544.04
26.02.27
26.02.27
9.16%
07.08.26
07.08.26
United Therapeutics
Start price
Target price
Perf. (%)
€364.40
26.09.25
26.09.25
€487.63
26.09.26
26.09.26
27.88%
07.08.26
07.08.26